BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24406376)

  • 1. Pitfalls in clinical assessment of neurotoxic diseases: negative effects of repeated diagnostic evaluation, illustrated by a clinical case.
    van Hout M; Hageman G; van Valen E
    Neurotoxicology; 2014 Dec; 45():247-52. PubMed ID: 24406376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.
    van Valen E; van Thriel C; Akila R; Nilson LN; Bast-Pettersen R; Sainio M; van Dijk F; van der Laan G; Verberk M; Wekking E
    Neurotoxicology; 2012 Aug; 33(4):710-26. PubMed ID: 22498091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functioning in patients with suspected chronic toxic encephalopathy: evidence for neuropsychological disturbances after controlling for insufficient effort.
    van Hout MS; Schmand B; Wekking EM; Deelman BG
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):296-303. PubMed ID: 16484635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.
    Verberk MM; van der Hoek JA; van Valen E; Wekking EM; van Hout MS; Hageman G; van der Laan G; van Dijk FJ
    Neurotoxicology; 2012 Aug; 33(4):742-52. PubMed ID: 22722000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting chronic solvent encephalopathy in occupations at risk.
    Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
    Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
    Spee T; van Valen E; van Duivenbooden C; van der Laan G
    Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of a computer-assisted neurobehavioral test battery in toxicant encephalopathy.
    Proctor SP; Letz R; White RF
    Neurotoxicology; 2000 Oct; 21(5):703-14. PubMed ID: 11130274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic solvent induced encephalopathy: a step forward.
    van der Laan G; Sainio M
    Neurotoxicology; 2012 Aug; 33(4):897-901. PubMed ID: 22560998
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishing stable test performance in tests from the Behavioral Assessment and Research System (BARS).
    Rohlman DS; Bailey SR; Brown M; Blanock M; Anger WK; McCauley L
    Neurotoxicology; 2000 Oct; 21(5):715-23. PubMed ID: 11130275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification accuracy of the Test of Memory Malingering in persons reporting exposure to environmental and industrial toxins: Results of a known-groups analysis.
    Greve KW; Bianchini KJ; Black FW; Heinly MT; Love JM; Swift DA; Ciota M
    Arch Clin Neuropsychol; 2006 Aug; 21(5):439-48. PubMed ID: 16870391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal event-related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Palmu K; Pitkonen M; Liljander S; Partanen JV; Akila R; Sainio M; Holm A
    Neurotoxicology; 2012 Aug; 33(4):703-9. PubMed ID: 22366255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurobehavioral tests in occupational medicine: diagnosis and prevention].
    Albini E; Benedetti L
    G Ital Med Lav Ergon; 2004; 26(3):251-4. PubMed ID: 15551956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P300 of auditory event related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Holm A; Akila R; Tuisku K; Kovala T; Sainio M
    Neurotoxicology; 2007 Nov; 28(6):1230-6. PubMed ID: 17869344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE).
    Visser I; Wekking EM; de Boer AG; de Joode EA; van Hout MS; van Dorsselaer S; Ruhé HG; Huijser J; van der Laan G; van Dijk FJ; Schene AH
    Neurotoxicology; 2011 Dec; 32(6):916-22. PubMed ID: 21609732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euroquest: the validity of a new symptom questionnaire.
    Karlson B; Osterberg K; Orbaek P
    Neurotoxicology; 2000 Oct; 21(5):783-9. PubMed ID: 11130283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification accuracy of the Portland digit recognition test in persons claiming exposure to environmental and industrial toxins.
    Greve KW; Bianchini KJ; Heinly MT; Love JM; Swift DA; Ciota M
    Arch Clin Neuropsychol; 2008 May; 23(3):341-50. PubMed ID: 18261882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malingering in toxic exposure: classification accuracy of reliable digit span and WAIS-III Digit Span scaled scores.
    Greve KW; Springer S; Bianchini KJ; Black FW; Heinly MT; Love JM; Swift DA; Ciota MA
    Assessment; 2007 Mar; 14(1):12-21. PubMed ID: 17314176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malingered neurocognitive dysfunction in neurotoxic exposure: an application of the Slick criteria.
    Bianchini KJ; Houston RJ; Greve KW; Irvin TR; Black FW; Swift DA; Tamimie RJ
    J Occup Environ Med; 2003 Oct; 45(10):1087-99. PubMed ID: 14534451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the rolling uterus finally gathered moss? Somatization and malingering of cognitive deficit in six cases of "toxic mold" exposure.
    Stone DC; Boone KB; Back-Madruga C; Lesser IM
    Clin Neuropsychol; 2006 Dec; 20(4):766-85. PubMed ID: 16980261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.
    van Hout MS; Schmand B; Wekking EM; Hageman G; Deelman BG
    Neurotoxicology; 2003 Aug; 24(4-5):547-51. PubMed ID: 12900068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.